Timothy M. Cox
Department of Medicine
University of Cambridge
Addenbrooke's Hospital
UK
Name/email consistency: low
- Damage at the cellular and organ levels in LSDs: possibility for prevention/reversibility with ERT. Cox, T.M., Beck, M. Acta. Paediatr. Suppl (2006)
- Biomarkers in lysosomal storage diseases: a review. Cox, T.M. Acta. Paediatr. Suppl (2005)
- Substrate reduction therapy for lysosomal storage diseases. Cox, T.M. Acta. Paediatr. Suppl (2005)
- The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. Cox, T.M., Aerts, J.M., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., Giralt, M., Heitner, R., Hollak, C., Hrebicek, M., Lewis, S., Mehta, A., Pastores, G.M., Rolfs, A., Miranda, M.C., Zimran, A. J. Inherit. Metab. Dis. (2003)
- The genetic consequences of our sweet tooth. Cox, T.M. Nat. Rev. Genet. (2002)
- Hemochromatosis--neonatal and young subjects. Cox, T.M., Halsall, D.J. Blood Cells Mol. Dis. (2002)
- Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. Cox, T.M. J. Inherit. Metab. Dis. (2001)